Source: International Congress 2018 – Pharmacological management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Balaguer Sole (Barcelona, Spain), M. Albayaty (London, United Kingdom), C. Astbury (Barcelona, Spain), L. Jimenez (Barcelona, Spain), U. Wahlby Hamren (Gothenburg, Sweden), B. Seoane (Barcelona, Spain), M. Malice (Barcelona, Spain), A. Lei (Barcelona, Spain), A. Aggarwal (Boston, United States of America), I. Psallidas (Gothenburg, Sweden), A. Mailleux (arnaud.mailleux@inserm.fr / INSERM U1152,Paris). Multiple ascending inhaled doses of AZD8871 in healthy males. 778

Member's Comments

No comment yet.

Related content which might interest you: Multiple ascending subcutaneous (SC) dose study of MEDI-563: Pharmacokinetics and immune response in adult asthmatics Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II Year: 2010 High doses of inhaled formoterol have less systemic effect in asthmatic children than high doses of inhaled terbutaline Source: Eur Respir J 2003; 22: Suppl. 45, 534s Year: 2003 Dissociated systemic tolerance induced by repeated low doses of inhaled endotoxins in healthy humans Source: Eur Respir J 2003; 22: Suppl. 45, 378s Year: 2003 Adult height in children treated with inhaled budesonide is normal but reached late Source: Eur Respir J 2006; 28: Suppl. 50, 709s Year: 2006 Adrenal function with low acth doses in asthmatic children with inhaled corticosteroids Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Low systemic exposure of NVA237, an inhaled once-daily anticholinergic bronchodilator, in healthy humans Source: Eur Respir J 2006; 28: Suppl. 50, 661s Year: 2006 Dose escalation study in healthy male subjects to investigate safety, tolerability and systemic exposure of orally inhaled single-doses of AP301 Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 Efficacy of low dose theophylline and inhaled corticosteroids in smokers with asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 A low-dose (1.0 mcg) rapid ACTH test and adrenal function in adult patients with bronchial asthma treated with inhaled corticosteroids Source: Eur Respir J 2007; 30: Suppl. 51, 69s Year: 2007 Efficacy of high dose inhaled DSCG on asthma control in young children Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008 Adrenal suppression in children using inhaled corticosteroids: neither recommended nor presribed doses identify those at risk Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma Year: 2004 Acute asthma treatment: comparison of formoterol and salbutamol given in cumulative doses in children Source: Eur Respir J 2001; 18: Suppl. 33, 122s Year: 2001 Comparison of systemic bioavailability of two formulations of budesonide nebulized suspension in healthy subjects Source: Annual Congress 2009 - New aspects of inhalation therapy Year: 2009 Efficacy of inhaled corticosteroids in children and adults with CF Source: ISSN=ISSN 1810-6838, ISBN=, page=188 Year: 2006 Inhaled LPS challenge in healthy subjects: a dose escalation study Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of AZD7594 after single and multiple ascending inhaled doses in healthy Japanese males Source: International Congress 2017 – COPD management Year: 2017 Reduced carotid atherosclerosis in asthmatic patients treated with inhaled corticosteroids Source: Eur Respir J 2010; 36: 503-508 Year: 2010 Effects of esomeprazole 40 mg twice-daily in adults with moderate to severe asthma who had been treated previously with inhaled steroids and long-acting β2-agonists Source: Eur Respir J 2005; 26: Suppl. 49, 278s Year: 2005 Effects of atorvastatin in asthmatic patients under treatment with high dose inhaled or oral steroid Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010 Laryngeal dysfunction is predominant in asthmatic women treated by inhaled corticosteroids Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021